Frontage Labs Expands Early-Phase Clinical Capabilities for Global Drug Development
Frontage's US operations are anchored by a modern 160?bed, 36,000?sq?ft phase-I clinical unit in Secaucus, New Jersey, designed to conduct large?scale phase-I and bioequivalence (BE) studies as well as radiolabeled human AME research.
Clinical Capabilities | 31/01/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy